Corteva, Inc. $CTVA Stock Holdings Boosted by Cwm LLC

Cwm LLC boosted its position in Corteva, Inc. (NYSE:CTVA) by 43.3% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 76,833 shares of the company’s stock after purchasing an additional 23,198 shares during the quarter. Cwm LLC’s holdings in Corteva were worth $5,196,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Moody National Bank Trust Division raised its holdings in shares of Corteva by 0.7% during the second quarter. Moody National Bank Trust Division now owns 22,139 shares of the company’s stock valued at $1,650,000 after buying an additional 143 shares during the last quarter. Ancora Advisors LLC raised its stake in Corteva by 0.8% during the 1st quarter. Ancora Advisors LLC now owns 18,567 shares of the company’s stock valued at $1,168,000 after acquiring an additional 150 shares in the last quarter. NORTHSTAR ASSET MANAGEMENT Co boosted its position in Corteva by 2.2% during the 2nd quarter. NORTHSTAR ASSET MANAGEMENT Co now owns 6,940 shares of the company’s stock worth $517,000 after acquiring an additional 150 shares during the period. NewEdge Advisors LLC grew its stake in shares of Corteva by 0.5% in the first quarter. NewEdge Advisors LLC now owns 31,455 shares of the company’s stock worth $1,979,000 after purchasing an additional 152 shares in the last quarter. Finally, Empirical Finance LLC increased its holdings in shares of Corteva by 0.6% during the second quarter. Empirical Finance LLC now owns 24,935 shares of the company’s stock valued at $1,858,000 after purchasing an additional 153 shares during the period. Institutional investors own 81.54% of the company’s stock.

Corteva Price Performance

NYSE CTVA opened at $67.39 on Wednesday. Corteva, Inc. has a 1 year low of $53.40 and a 1 year high of $77.41. The business’s fifty day moving average is $65.29 and its two-hundred day moving average is $69.07. The stock has a market capitalization of $45.54 billion, a P/E ratio of 28.80, a P/E/G ratio of 1.53 and a beta of 0.74. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.07 and a current ratio of 1.58.

Corteva (NYSE:CTVA) last issued its earnings results on Tuesday, November 4th. The company reported ($0.23) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.49) by $0.26. Corteva had a return on equity of 9.37% and a net margin of 9.19%.The business had revenue of $2.62 billion for the quarter, compared to analysts’ expectations of $2.47 billion. During the same period in the previous year, the firm posted ($0.49) EPS. The company’s quarterly revenue was up 6.5% on a year-over-year basis. On average, research analysts forecast that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, December 15th. Shareholders of record on Monday, December 1st were paid a dividend of $0.18 per share. The ex-dividend date of this dividend was Monday, December 1st. This represents a $0.72 dividend on an annualized basis and a yield of 1.1%. Corteva’s dividend payout ratio is currently 30.77%.

Analyst Upgrades and Downgrades

CTVA has been the subject of several research analyst reports. UBS Group reduced their price objective on shares of Corteva from $85.00 to $81.00 and set a “buy” rating for the company in a report on Thursday, October 30th. KeyCorp reiterated a “sector weight” rating on shares of Corteva in a report on Friday, October 3rd. BMO Capital Markets set a $86.00 price objective on shares of Corteva in a research note on Monday, September 15th. Citigroup upgraded Corteva from a “neutral” rating to a “positive” rating in a research report on Thursday, December 18th. Finally, Wolfe Research lifted their price target on Corteva from $79.00 to $80.00 and gave the company an “outperform” rating in a research report on Thursday, November 6th. Sixteen equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $78.21.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.